Cargando…
Telomere Attrition and p53 Response 1 (TAPR1): a new player in cancer biology?
Autores principales: | dos Santos, Gabriel Arantes, Reis, Sabrina T., Leite, Katia Ramos Moreira, Srougi, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158669/ https://www.ncbi.nlm.nih.gov/pubmed/34133663 http://dx.doi.org/10.6061/clinics/2021/e2997 |
Ejemplares similares
-
Stressed ends: telomere attrition in chronic diseases()
por: Fok, Wilson Chun, et al.
Publicado: (2017) -
A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition
por: Benslimane, Yahya, et al.
Publicado: (2021) -
Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
por: dos Santos, Gabriel Arantes, et al.
Publicado: (2021) -
Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres
por: Byrjalsen, Anna, et al.
Publicado: (2023) -
Telomere Attrition Due to Infection
por: Ilmonen, Petteri, et al.
Publicado: (2008)